MedTrace Logo

Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension

NCT02265965 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-05-19

Study results available
· View outcomes & findings →

Summary

Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.

Conditions

  • Prolonged Second Stage of Labor

Interventions

DRUG

intravenous nitroglycerin

Infusion at started at time of hysterotomy and stopped at neonate delivery

Sponsors & Collaborators

Principal Investigators

  • Jennifer M Lucero, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-07-01
Completion
2018-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265965 on ClinicalTrials.gov